Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Caveolin-1 inhibits breast cancer growth and metastasis

Oncogene volume 23, pages 7893–7897 (2004)Cite this article

Abstract

Caveolin-1 was identified in a screen for genes involved in breast cancer progression. Caveolin-1 is the major protein component of caveolae, flask-shaped invaginations found in a number of different cell types. Using an orthotopic model of spontaneous breast cancer metastasis, caveolin-1 was found to be expressed in low and non-metastatic primary tumors, but at much lower levels in highly metastatic 4T1.2 and 4T1.13 tumors. Exogenous expression of caveolin-1 at moderate levels in 4T1.2 cells was sufficient to suppress primary tumor growth after inoculation of cells into the mammary gland. Expression of high levels of caveolin-1 also inhibited subsequent metastasis to distant organs. Cells expressing high levels of caveolin-1 showed reduced capacity to invade Matrigel, diminished response to laminin-1 stimulation and decreased metastasis to lung and bone. This study provides the first functional evidence that caveolin-1 regulates primary breast tumor growth and spontaneous metastasis of breast cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Aslakson CJ and Miller FR . (1992). Cancer Res., 52, 1399–1405.

  • Bender FC, Reymond MA, Bron C and Quest AF . (2000). Cancer Res., 60, 5870–5878.

  • Engelman JA, Zhang XL and Lisanti MP . (1999). FEBS Lett., 448, 221–230.

  • Fiucci G, Ravid D, Reich R and Liscovitch M . (2002). Oncogene, 21, 2365–2375.

  • Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP and Sessa WC . (1997). J. Biol. Chem., 272, 25437–25440.

  • Giancotti FG and Ruoslahti E . (1999). Science, 285, 1028–1032.

  • Hayashi K, Matsuda S, Machida K, Yamamoto T, Fukuda Y, Nimura Y, Hayakawa T and Hamaguchi M . (2001). Cancer Res., 61, 2361–2364.

  • Ho CC, Huang PH, Huang HY, Chen YH, Yang PC and Hsu SM . (2002). Am. J. Pathol., 161, 1647–1656.

  • Hurlstone AF, Reid G, Reeves JR, Fraser J, Strathdee G, Rahilly M, Parkinson EK and Black DM . (1999). Oncogene, 18, 1881–1890.

  • Kanzaki M and Pessin JE . (2002). J. Biol. Chem., 277, 25867–25869.

  • Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T, Okushiba S, Kondo S and Katoh H . (2002). Cancer, 94, 929–933.

  • Lee H, Park DS, Razani B, Russell RG, Pestell RG and Lisanti MP . (2002). Am. J. Pathol., 161, 1357–1369.

  • Lee SW, Reimer CL, Oh P, Campbell DB and Schnitzer JE . (1998). Oncogene, 16, 1391–1397.

  • Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, Ho P, Lowen D, Javni J, Miller FR, Slavin J and Anderson RL . (1999). Clin. Exp. Metast., 17, 163–170.

  • Li L, Yang G, Ebara S, Satoh T, Nasu Y, Timme T, Ren C, Wang J, Tahir S and Thompson T . (2001). Cancer Res., 61, 4386–4392.

  • Liu J, Lee P, Galbiati F, Kitsis RN and Lisanti MP . (2001). Am. J. Physiol. Cell. Physiol., 280, C823–35.

  • Mundy DI, Machleidt T, Ying YS, Anderson RG and Bloom GS . (2002). J. Cell. Sci., 115, 4327–4339.

  • Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV and Simons K . (1995). Proc. Natl. Acad. Sci. USA, 92, 10339–10343.

  • Ostermeyer AG, Paci JM, Zeng Y, Lublin DM, Munro S and Brown DA . (2001). J. Cell Biol., 152, 1071–1078.

  • Park DS, Lee H, Frank PG, Razani B, Nguyen AV, Parlow AF, Russell RG, Hulit J, Pestell RG and Lisanti MP . (2002). Mol. Cell. Biol., 13, 3416–3430.

  • Parker BS, Eckhardt B and Anderson RL . (2004). Bone Metastasis Singh G and Orr FW (eds). Kluwer Press: The Netherlands, pp. 1–21.

    Book  Google Scholar 

  • Pol A, Martin S, Fernandez MA, Ferguson C, Carozzi A, Luetterforst R, Enrich C and Parton RG . (2004). Mol. Cell. Biol., 15, 99–110.

  • Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou Jr H, Kneitz B, Lagaud G, Christ GJ, Edelmann W and Lisanti MP . (2001). J. Biol. Chem., 276, 38121–38138.

  • Sager R, Sheng S, Anisowicz A, Sotiropoulou G, Zou Z, Stenman G, Swisshelm K, Chen Z, Hendrix MJ and Pemberton P . (1994). Cold Spring Harb. Symp. Quant. Biol., 59, 537–546.

  • Simons K and Toomre D . (2000). Nat. Rev. Mol. Cell. Biol., 1, 31–39.

  • Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T and Lisanti MP . (1999). Mol. Cell. Biol., 19, 7289–7304.

  • Smart EJ, Ying Y, Donzell WC and Anderson RG . (1996). J. Biol. Chem., 271, 29427–29435.

  • Tester AM, Sharp JA, Dhanesuan N, Waltham M and Thompson EW . (2002). Clin. Exp. Metast., 19, 377–383.

  • Wary KK, Mariotti A, Zurzolo C and Giancotti FG . (1998). Cell, 94, 625–634.

  • Wei Y, Yang X, Liu Q, Wilkins JA and Chapman HA . (1999). J. Cell Biol., 144, 1285–1294.

  • Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM and Schneider U . (2001). Am. J. Pathol., 158, 833–839.

  • Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, Nasu Y, Bangma CH, Kattan MW, Scardino PT and Thompson TC . (1998). Clin. Cancer Res., 4, 1873–1880.

  • Yang G, Truong LD, Wheeler TM and Thompson TC . (1999). Cancer Res., 59, 5719–5723.

  • Zenklusen JC, Bieche I, Lidereau R and Conti CJ . (1994). Proc. Natl. Acad. Sci. USA, 91, 12155–12158.

  • Zenklusen JC, Conti CJ and Green ED . (2001). Nat. Genet., 27, 392–398.

Download references

Acknowledgements

We thank Dr M Tavaria for establishing the RTQ–PCR assay for tumor burden, Ms A Herr for assistance with microscopy, the Peter Mac Microarray Facility for assistance with the cDNA arrays, Dr N Pouliot, Ms C Restall and Dr R Parton for constructive discussions. The kind donation of cells and reagents from Dr Fred Miller, Dr Gary Nolan and Dr Richard Anderson is acknowledged. This work was supported by a Susan Komen Foundation Dissertation Award (EKS) and by grants from the US Department of Army (DAMD17-98-1-8144) (RLA) and the NCI/NIH (ROI CA 90291) (RLA).

Author information

Author notes

  1. Erica K Sloan

    Present address: Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA, 90095-1678, USA

Authors and Affiliations

  1. Peter MacCallum Cancer Centre, Locked Bag #1, A'Beckett Street, Melbourne, 8006, Victoria, Australia

    Erica K Sloan, Kym L Stanley & Robin L Anderson

Authors
  1. Erica K Sloan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kym L Stanley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robin L Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robin L Anderson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sloan, E., Stanley, K. & Anderson, R. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 23, 7893–7897 (2004). https://doi.org/10.1038/sj.onc.1208062

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208062

Keywords

This article is cited by

Search

Advanced search

Quick links